On August 31, 2023 Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, reported that management will participate in two investor conferences in September (Press release, Anixa Biosciences, AUG 31, 2023, View Source [SID1234634794]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 25th Annual Global Investment Conference: Anixa’s pre-recorded presentation will be available on demand during the event for all registered attendees. Beginning on Monday, September 11, 2023, the presentation will also be available on the Company’s website at Investor Relations/Events & Presentations.

2023 Cantor Global Healthcare Conference: Anixa management is scheduled to present on Thursday, September 28, 2023 at 8:00 AM ET in New York City. The presentation will be broadcast live and archived on the Company’s website at Investor Relations/Events & Presentations.

Management will be available for one-on-one meetings with interested investors at both conferences.